Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Redox metabolism: ROS as specific molecular regulators of cell signaling and function
Lennicke, C., & Cochemé, H. M. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.018 · Cited by 1,246
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Self-citationAntar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review
Saha, T., Del Caño, R., Mahato, K., De la Paz, E., Chen, C., Ding, S., Yin, L., & Wang, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00078 · Cited by 442
Alam, S., Sarker, M. M. R., Sultana, T. N., Chowdhury, M. N. R., Rashid, M. A., Chaity, N. I., Zhao, C., Xiao, J., Hafez, E. E., Khan, S. A., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.800714 · Cited by 349
“The clinical consequences of the gut microbiome are still being researched, and more study is needed to better understand the link between gut bacteria and type 2 diabetes mellitus (26).”
BackgroundMłynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031094 · Cited by 328
“Therefore, the immoderate production of these hormones may promote IR [53,54].”
Overview of oxidative stress and inflammation in diabetes
Weinberg Sibony, R., Segev, O., Dor, S., & Raz, I. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.70014 · Cited by 292
Enrichr-KG: bridging enrichment analysis across multiple libraries
Evangelista, J. E., Xie, Z., Marino, G. B., Nguyen, N., Clarke, D. J. B., & Ma’ayan, A. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad393 · Cited by 233
“Type 2 diabetes mellitus is a common metabolic disease characterized by an inability to secrete insulin by pancreatic beta cells, and / or a loss in the ability of cells and tissues to respond to insulin ( 85 ).”
BackgroundCiumărnean, L., Milaciu, M. V., Negrean, V., Orășan, O. H., Vesa, S. C., Sălăgean, O., Iluţ, S., & Vlaicu, S. I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010207 · Cited by 229
“The substrate of this pathology is an increased insulin resistance, the end result being a state of chronic hyperglycemia [40].”
BackgroundThe Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
The mechanism of ferroptosis and its related diseases
Feng, S., Tang, D., Wang, Y., Li, X., Bao, H., Tang, C., Dong, X., Li, X., Yang, Q., Yan, Y., et al. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00142-2 · Cited by 212
A Review on Role of Guava on Diabetes Patients
A, G., & P, D. (2024) · International Journal of Innovative Science and Research Technology (IJISRT) · doi:10.38124/ijisrt/ijisrt24sep500 · Cited by 214
“Main risk factors, including mitochondrial dysfunction, genetic predispositions, intestinal dysbiosis, obesity, and lifestyle factors (Galicia-Garcia et al., 2020).”
BackgroundChaudhary, M. R., Chaudhary, S., Sharma, Y., Singh, T. A., Mishra, A. K., Sharma, S., & Mehdi, M. M. (2023) · Biogerontology · doi:10.1007/s10522-023-10050-1 · Cited by 205
The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders
Szymczak-Pajor, I., Drzewoski, J., & Śliwińska, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186644 · Cited by 201
“Physiologically, insulin promotes TAG accumulation in adipocytes via the stimulation of preadipocytes’ differentiation to adipocytes, elevation of glucose uptake and lipogenesis, as well as suppression of lipolysis [88,97].”
BackgroundDiet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics
Li, D., Li, Y., Yang, S., Lu, J., Jin, X., & Wu, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113290 · Cited by 182
Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
Kumar, S., Behl, T., Sachdeva, M., Sehgal, A., Kumari, S., Kumar, A., Kaur, G., Yadav, H. N., & Bungau, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118661 · Cited by 173
β-glucans: a potential source for maintaining gut microbiota and the immune system
Singh, R. P., & Bhardwaj, A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1143682 · Cited by 160
Insights from multi-omics integration in complex disease primary tissues
Kreitmaier, P., Katsoula, G., & Zeggini, E. (2023) · Trends in Genetics · doi:10.1016/j.tig.2022.08.005 · Cited by 161
Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)—New Aspects
Baum, P., Toyka, K. V., Blüher, M., Kosacka, J., & Nowicki, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910835 · Cited by 209
Polyol pathway and redox balance in diabetes
Garg, S. S., & Gupta, J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106326 · Cited by 168
Bioactive Peptides as Potential Nutraceuticals for Diabetes Therapy: A Comprehensive Review
Antony, P., & Vijayan, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169059 · Cited by 161
“Blood sugar levels are largely regulated by the action of the two peptide hormones insulin and glucagon [33].”
BackgroundBlood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 139
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
Kitamura, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043219 · Cited by 155
Orellana-Paucar, A. M. (2023) · Molecules · doi:10.3390/molecules28031258 · Cited by 188
Fenta, E. T., Eshetu, H. B., Kebede, N., Bogale, E. K., Zewdie, A., Kassie, T. D., Anagaw, T. F., Mazengia, E. M., & Gelaw, S. S. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01202-x · Cited by 208
“Diabetes is a complicated, chronic condition that need for ongoing medical attention as well as multiple risk-reduction measures beyond glucose con-trol [3, 4].”
BackgroundSzymczak-Pajor, I., Miazek, K., Selmi, A., Balcerczyk, A., & Śliwińska, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020956 · Cited by 156
“Insulin promotes the accumulation of TG in adipocytes by increasing the glucose uptake and lipogenesis, activating the differentiation of pre-adipocytes to adipocytes and inhibiting lipolysis [116,117].”
BackgroundYang, T., Feng, Q., Guo, F., Shao, M., Song, Y., Ren, G., Zhao, L., Qin, G., & Zhao, Y. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00824-9 · Cited by 179
Andreadi, A., Bellia, A., Daniele, N. D., Meloni, M., Lauro, R., Della‐Morte, D., & Lauro, D. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.11.010 · Cited by 144
Costanzo, M. C., von Grotthuss, M., Massung, J., Jang, D., Caulkins, L., Koesterer, R., Gilbert, C., Welch, R., Kudtarkar, P., Hoang, Q., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.001 · Cited by 147
Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions
Zhao, L., Hu, H., Zhang, L., Liu, Z., Huang, Y., Liu, Q., Jin, L., Zhu, M., & Zhang, L. (2024) · MedComm · doi:10.1002/mco2.516 · Cited by 174
Epigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Ling, C., Bacos, K., & Rönn, T. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00671-w · Cited by 161
Marzook, A., Tomas, A., & Jones, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.678055 · Cited by 121
“Type 2 diabetes (T2D), the commonest form, arises due to a combination of genetic and lifestyle factors that contribute to defective production of insulin from pancreatic beta cells and resistance to its action in peripheral and central tissues (2).”
BackgroundEpigenetic Mechanisms of Aging and Aging-Associated Diseases
la Torre, A., Vecchio, F. L., & Greco, A. (2023) · Cells · doi:10.3390/cells12081163 · Cited by 150
Yu, M. S., Qin, K. H., Fan, J., Zhao, G., Zhao, P., Zeng, W., Chen, C., Wang, A., Wang, Y., Zhong, J., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.04.042 · Cited by 147
Therapeutic application of natural products: NAD+ metabolism as potential target
Guo, C., Huang, Q., Wang, Y., Yao, Y., Li, J., Chen, J., Wu, M., Zhang, Z., Mingyao, E., Qi, H., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154768 · Cited by 127
Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology
Ojo, O. A., Ibrahim, H. S., Rotimi, D. E., Ogunlakin, A. D., & Ojo, A. B. (2023) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2023.100247 · Cited by 224
Triple threat: how diabetes results in worsened bacterial infections
Darwitz, B. P., Genito, C. J., & Thurlow, L. R. (2024) · Infection and Immunity · doi:10.1128/iai.00509-23 · Cited by 166
mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process
Marafie, S. K., Al‐Mulla, F., & Abubaker, J. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116141 · Cited by 128
Known and potential health benefits and mechanisms of blueberry anthocyanins: A review
Wu, Y., Han, T., Yang, H., Lyu, L., Li, W., & Li, W. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103050 · Cited by 114
Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology
Liu, Z., Wang, M., Zhang, C., Zhou, S., & Ji, G. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s346648 · Cited by 119
“Patients often have carbohydrate, fat, and protein metabolic disorders due to insulin deficiency or (and) insulin resistance.(79) Diabetes is also a global pandemic.”
Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
Dhokte, S., & Czaja, K. (2024) · Nutrients · doi:10.3390/nu16071015 · Cited by 133
“Type 2 diabetes makes up the overwhelming majority of diabetes cases and is characterized by insulin resistance in several tissues, including muscle, liver, and adipose tissue [4,5,7,9].”
BackgroundInfluentialKynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
Kozieł, K., & Urbańska, E. M. (2023) · Cells · doi:10.3390/cells12030460 · Cited by 111
“Under these conditions, β-cells are exposed to deleterious factors, such as inflammation, endoplasmic reticulum dysfunction, metabolic stress or amyloidosis, which altogether may lead to a loss of islet integrity [72].”
BackgroundImpact of Lipids on Insulin Resistance: Insights from Human and Animal Studies
Elkanawati, R. Y., Sumiwi, S. A., & Levita, J. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s468147 · Cited by 132
“75,76 This leads to hyperinsulinemia, and over time, pancreatic exhaustion results in elevated blood glucose and T2DM.”
BackgroundMicroenvironmental dynamics of diabetic wounds and insights for hydrogel-based therapeutics
Zhao, Y., Zhao, Y., Xu, B., Liu, H., & Chang, Q. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241253290 · Cited by 108
“78,79 Continual oxidative stress and the accumulation of excessive AGEs can impair the function of two receptors: AGE-R1 and Sirtuin1 (SIRT-1).”
BackgroundThe central role of the gut microbiota in the pathophysiology and management of type 2 diabetes
Baars, D. P., Fondevila, M. F., Meijnikman, A. S., & Nieuwdorp, M. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.017 · Cited by 119
Guo, H., Wu, H., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086978 · Cited by 122
“The impairment of any link may lead to a disruption in glucose homeostasis, resulting in insulin resistance and ultimately developing into type 2 diabetes [42].”
BackgroundZepeda-Hernández, A., García-Amezquita, L. E., Requena, T., & García‐Cayuela, T. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110208 · Cited by 106
Inflammation as A Precursor of Atherothrombosis, Diabetes and Early Vascular Aging
Barbu, E., Popescu, M.-R., Popescu, A.-C., & Balanescu, S. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020963 · Cited by 107
“Altered glucose tolerance and hyperglycemia are the main features and are the result of an absolute or relative insulin deficiency or tissue resistance to insulin action [18].”
BackgroundArjunan, A., Sah, D. K., Woo, M., & Song, J. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-00966-z · Cited by 111
López-Pedrosa, J. M., Camprubí-Robles, M., Rolo, G. G., Lopez-Gonzalez, A., García‐Almeida, J. M., Sanz‐París, A., & Rueda, R. (2024) · Nutrients · doi:10.3390/nu16010172 · Cited by 116
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Dutta, B. J., Singh, S., Seksaria, S., Gupta, G. D., & Singh, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106358 · Cited by 102
Type 2 diabetes mellitus – conventional therapies and future perspectives in innovative treatment
Gieroba, B., Kryska, A., & Sroka‐Bartnicka, A. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102037 · Cited by 210
“Prepared based on [3,5,22,23]. various systemic dysfunctions and is often a result of diabetic complications involving both micro-and macrovascular damage.”
Bioactive compounds in fermented foods: Health benefits, safety, and future perspectives
Fitsum, S., Gebreyohannes, G., & Sbhatu, D. B. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.101097 · Cited by 99
Fabozzi, G., Verdone, G., Allori, M., Cimadomo, D., Tatone, C., Stuppia, L., Franzago, M., Ubaldi, N., Vaiarelli, A., Ubaldi, F. M., et al. (2022) · Nutrients · doi:10.3390/nu14091918 · Cited by 108
“Of course, again, the interaction between genetics and the environment is crucial [251].”
BackgroundLuo, P., Cao, Y., Li, P., Li, W., Song, Z. J., Fu, Z., Zhou, H., Yi, X., Zhu, L., & Zhu, S. (2022) · Medicina · doi:10.3390/medicina58070876 · Cited by 104
“Discussion T2DM is characterized by impaired glucose and lipid metabolism associated with IR [6,19].”
BackgroundSchiweck, C., Thanarajah, S. E., Aichholzer, M., Matura, S., Reif, A., Vrieze, E., Weigert, A., & Visekruna, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158272 · Cited by 85
“In contrast to Type 2 diabetes, where peripheral cells become resistant to insulin over time [67], in T1D, pancreatic insulin-producing beta cells are destroyed by autoreactive T cells early on, with a particular pathogenic role of CD4+ and CD8+ cells [68].”
BackgroundEmerging role of METTL3 in inflammatory diseases: mechanisms and therapeutic applications
Song, B., Zeng, Y., Cao, Y., Zhang, J., Xu, C., Pan, Y., Zhao, X., & Liu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1221609 · Cited by 82
The complex role of Wnt ligands in type 2 diabetes mellitus and related complications
Nie, X., Wei, X., Ma, H., Fan, L., & Chen, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16663 · Cited by 81
de Paiva, I. H. R., da Silva, R. S., Mendonça, I. P., de Souza, J. R. B., & Peixoto, C. A. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10142-w · Cited by 75
Pan, J., Zhang, Q., Zhang, C., Yang, W., Liu, H., Lv, Z., Liu, J., & Jiao, Z. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.892426 · Cited by 89
“It is characterized by impaired insulin secretion and increased insulin resistance, which lead to elevated blood glucose levels (3, 4).”
BackgroundThe Structure and Functions of PRMT5 in Human Diseases
Motolani, A., Martin, M., Sun, M., & Lu, T. (2021) · Life · doi:10.3390/life11101074 · Cited by 87
Udaya Rajesh, R., & Sangeetha, D. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.104881 · Cited by 88
Okoro, B. C., Dokunmu, T. M., Okafor, E., Taiwo, I., Israel, E. N., Olusegun, D. O., Bella-Omunagbe, M., Uche, M. E., Ugbogu, E. A., & Iweala, E. (2023) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2023.100273 · Cited by 104
Ponce-Lopez, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094209 · Cited by 75
“Risk factors for T2D include obesity (particularly visceral fat deposition), physical inactivity, being male, advanced age, certain ethnicities, sleep deprivation, urbanization, and low socioeconomic status [39].”
Kha, P. T., Nguyen, T., Yi, J. M., Kim, G. S., Yun, H. R., Kim, H. K., & Won, J. C. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00958-6 · Cited by 83
The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Ağagündüz, D., İçer, M. A., Yeşildemir, Ö., Koçak, T., Koçyiğit, E., & Capasso, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04088-5 · Cited by 89
“Genetic, metabolic, lifestyle, and dietary patterns are among the most influential determinants of T2DM [6].”
BackgroundModification of lipoprotein metabolism and function driving atherogenesis in diabetes
Luciani, L., Pedrelli, M., & Parini, P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117545 · Cited by 72
Aktaş, G. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.10426 · Cited by 78
Benefits of Natural Antioxidants on Oral Health
Malcangi, G., Patano, A., Ciocia, A. M., Netti, A., Viapiano, F., Palumbo, I., Trilli, I., Guglielmo, M., Inchingolo, A. D., Dipalma, G., et al. (2023) · Antioxidants · doi:10.3390/antiox12061309 · Cited by 102
Liu, X., Huang, L., Zhang, X., & Xu, X. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140221 · Cited by 78
Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
Michałowska, J., Miller-Kasprzak, E., & Bogdański, P. (2021) · Nutrients · doi:10.3390/nu13020351 · Cited by 68
Khalil, A. S. M., Giribabu, N., Yelumalai, S., Shahzad, H., Kilari, E. K., & Salleh, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119605 · Cited by 82
Lei, W., Cheng, Y., Liu, X., Gao, J., Zhu, Z., Ding, W., Xu, X., Li, Y., Ling, Z., Jiang, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582119 · Cited by 68
Edo, G. I., Samuel, P. O., Jikah, A. N., Oloni, G. O., Ifejika, M. N., Oghenegueke, O., Ossai, S., Ajokpaoghene, M. O., Asaah, E. U., Uloho, P. O., et al. (2023) · Food Chemistry Advances · doi:10.1016/j.focha.2023.100437 · Cited by 90
Genetic and inflammatory factors underlying gestational diabetes mellitus: a review
Ray, G. W., Zeng, Q., Kusi, P., Zhang, H., Shao, T., Yang, T., Wei, Y., Li, M., Che, X., & Guo, R. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1399694 · Cited by 86
“In individuals with normal glucose tolerance, the pancreatic beta cells adapt to these changes by producing higher levels of insulin, which helps maintain normal glucose levels (112).”
BackgroundAdvances in the structures, mechanisms and targeting of molecular chaperones
Gu, J., He, Y., He, C., Zhang, Q., Huang, Q., Bai, S., Wang, R., You, Q., & Wang, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02166-2 · Cited by 85
“346 Some studies have shown the important role of HSP70 in insulin resistance, which further leads to T2DM.”
Targeting aging and age-related diseases with vaccines
Wu, R., Sun, F., Zhang, W., Ren, J., & Liu, G.-H. (2024) · Nature Aging · doi:10.1038/s43587-024-00597-0 · Cited by 66
“The complex pathological status of T2D and the interaction of biological pathways may contribute to the limited benefit observed in vaccine therapy against T2D 77 .”
Ismael, S., Silvestre, M. P., Vasques, M., Araújo, J. R., Morais, J., Duarte, M. I., Pestana, D., Faria, A., Pereira‐Leal, J. B., Vaz, J., et al. (2021) · Nutrients · doi:10.3390/nu13041228 · Cited by 83
“Weight gain and body mass are central to the rising incidence of type 2 diabetes through several mechanisms, inducing inflammation and oxidative stress which may lead to β-cell damage and dysfunction [7].”
BackgroundFerroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?
Duan, J.-Y., Lin, X., Xu, F., Shan, S., Guo, B., Li, F., Wang, Y., Zheng, M.-H., Xu, Q.-S., Lei, L.-M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701788 · Cited by 73
Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction
Sun, M., Chen, W., Wu, S., & Zhang, J. (2023) · Brain · doi:10.1093/brain/awad366 · Cited by 78
A Comprehensive Review on Weight Loss Associated with Anti-Diabetic Medications
Haddad, F., Dokmak, G., Bader, M., & Karaman, R. (2023) · Life · doi:10.3390/life13041012 · Cited by 79
“According to the World Health Organization (WHO), diabetes mellitus is a long-term metabolic condition marked by hyperglycemia that over time can harm the heart, blood vessels, eyes, kidneys, and nerves [1,2].”
BackgroundInfluentialInsulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases
Sousa, L., Guarda, M., Meneses, M. J., Macedo, M. P., & Miranda, H. V. (2021) · The Journal of Pathology · doi:10.1002/path.5777 · Cited by 77
Garlic: A systematic review of the effects on cardiovascular diseases
Imaizumi, V. M., Laurindo, L. F., Manzan, B., Guiguer, É. L., Oshiiwa, M., Otoboni, A. M. M. B., Araújo, A. C., Tofano, R. J., & Barbalho, S. M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2043821 · Cited by 78
Kasai, S., Kokubu, D., Mizukami, H., & Itoh, K. (2023) · Biomolecules · doi:10.3390/biom13101544 · Cited by 76
“Although this review focuses on the early events of IR and the role of Nrf2 in pathophysiology [75], chronic hyperglycemia leads to oxidative stress and defective glucose-stimulated insulin secretion (GSIS) in β -cells (i.e., β - cell failure) during the progression to T2D following IR [76].”
BackgroundLiu, Y., Yang, L., & Cui, Y. (2024) · Microsystems & Nanoengineering · doi:10.1038/s41378-024-00663-y · Cited by 73
“Diabetes mellitus is a metabolic illness with a high level of blood glucose, and diabetes can cause numerous consequences, including heart disease, renal disease, retino-pathy, and neuropathy 1,2 .”
BackgroundAn Overview of Wearable and Implantable Electrochemical Glucose Sensors
Zhu, B., Li, X., Zhou, L., & Su, B. (2021) · Electroanalysis · doi:10.1002/elan.202100273 · Cited by 68
In Vitro and In Vivo Antidiabetic Potential of Monoterpenoids: An Update
Kury, L. T. A., Abdoh, A., Ikbariah, K., Sadek, B. S., & Mahgoub, M. (2021) · Molecules · doi:10.3390/molecules27010182 · Cited by 78
“These metabolic processes are finely tuned by the actions of insulin and glucagon, where insulin promotes glucose storage and glycogen synthesis, while glucagon promotes hepatic glucose production and glycogen breakdown [35,37,38].”
BackgroundAnsari, M. A., Chauhan, W., Shoaib, S., Alyahya, S. A., Ali, M., Ashraf, H., Alomary, M. N., & Al-Suhaimi, E. A. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01369-3 · Cited by 73
“Therefore, a pro-oxidant environment causes ER stress, superoxide (O2) generation, NADPH oxidase (NOX) activation, and mitochondrial dysfunction [4].”
BackgroundKeratin-Based Nanoparticles as Drug Delivery Carriers
Ferroni, C., & Varchi, G. (2021) · Applied Sciences · doi:10.3390/app11209417 · Cited by 62
“Patients affected by type II diabetes mellitus (T2DM) experience compromised parameters of glucose metabolism and removal along with peripheral insulin resistance, which leads to the development of complications such as chronic hyperglycemia, and acute glycemic fluctuations [28].”
BackgroundVasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides
Glavaš, M., Gitlin‐Domagalska, A., Dębowski, D., Ptaszyńska, N., Łęgowska, A., & Rolka, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063068 · Cited by 76
“, resistance to insulin results in Diabetes mellitus type 2 [6,7], while excess and aggregation of amyloid β peptide has a role in Alzheimer’s disease progress [8,9].”
BackgroundBiomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications
Goycheva, P., Petkova-Parlapanska, K., Georgieva, E., Karamalakova, Y. D., & Nikolova, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713541 · Cited by 81
“This oxidative stress can lead to inflammation, endothelial dysfunction, and fibrosis, ultimately resulting in kidney damage [18].”
BackgroundKumar, V., Singh, D. D., Lakhawat, S. S., Yasmeen, N., Pandey, A., & Singla, R. K. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6852276 · Cited by 70
“)e postprandial concentration of glucose is regulated by the release of insulin from the pancreatic beta islet of Langerhans which also activates phospholipases [32, 33].”
BackgroundCrosstalk between autophagy and insulin resistance: evidence from different tissues
Sadeghi, A., Niknam, M., Momeni‐Moghaddam, M. A., Shabani, M., Aria, H., Bastin, A., Teimouri, M., Meshkani, R., & Akbari, H. (2023) · European journal of medical research · doi:10.1186/s40001-023-01424-9 · Cited by 77
Scarpa, E. S., Antonelli, A., Balercia, G., Sabatelli, S., Maggi, F., Caprioli, G., Giacchetti, G., & Micucci, M. (2024) · Biomolecules · doi:10.3390/biom14070836 · Cited by 79
Yapislar, H., & Gurler, E. B. (2024) · Biomedicines · doi:10.3390/biomedicines12091958 · Cited by 64
“Factors contributing to insulin resistance include obesity, sedentary lifestyles, poor diet, and genetic predisposition [1,5].”
BackgroundDysfunctions, molecular mechanisms, and therapeutic strategies of pancreatic β-cells in diabetes
Prasad, M. K., Mohandas, S., & Ramkumar, K. M. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01854-0 · Cited by 62
“Hyperglycemia and dyslipidemia are known factors that precipitate a reduced beta cell mass and contribute to the increased beta cell apoptosis in T2DM [9, 34].”
BackgroundSoy protein, bioactive peptides, and isoflavones: A review of their safety and health benefits
Tan, S. T., Tan, S. S., & Tan, C. X. (2023) · PharmaNutrition · doi:10.1016/j.phanu.2023.100352 · Cited by 74
Pereira, L., & Valado, A. (2023) · Life · doi:10.3390/life13091831 · Cited by 76
“Type 2 diabetes mellitus (T2DM) is the most prevalent form, accounting for approximately 90% of all diabetes cases [3].”
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.